glp-1 breath Medications – Community Education Considering Starting on a GLP-1?

The STEP 1 trial extension, which followed patients for a year after stopping semaglutide, showed participants had regained two-thirds of their lost weight by the end of that year (Stanford Medicine, 2026)

It provides context for personalized medication conversations with your providernot exact outcome prediction

This article was published originally on October 26, 2020.

Lean Mass Loss Review (Obesity Reviews): A systematic review of the effect of semaglutide on Lean Mass (Bikou O, et al.) Muscle Mass & Metabolic Rate (AJCN): Skeletal muscle mass and distribution in 468 men and women (Janssen I, et al., 2000) InBody USA White Paper: Understanding Body Fat & Muscle Categories Explains why BMI is insufficient and how Direct Segmental Multi-frequency BIA (DSM-BIA) works

New England Journal of Medicine , 379 (22), 21402150